Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Invested Capital (2024)

Historic Return on Invested Capital for Agios Pharmaceuticals (AGIO) over the last 6 years, with Q3 2025 value amounting to 0.4%.

  • Agios Pharmaceuticals' Return on Invested Capital fell 700.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.34% for FY2024, which is N/A changed from last year.
  • Agios Pharmaceuticals' Return on Invested Capital amounted to 0.4% in Q3 2025, which was down 700.0% from 0.25% recorded in Q4 2024.
  • Agios Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.25% for Q4 2024, and its period low was 0.46% during Q4 2023.
  • In the last 3 years, Agios Pharmaceuticals' Return on Invested Capital had a median value of 0.4% in 2025 and averaged 0.37%.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Invested Capital skyrocketed by 2100bps in 2024, and later tumbled by -700bps in 2025.
  • Agios Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.46% in 2023, then surged by 45bps to 0.25% in 2024, then crashed by -57bps to 0.4% in 2025.
  • Its Return on Invested Capital was 0.4% in Q3 2025, compared to 0.25% in Q4 2024 and 0.33% in Q3 2024.